VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment Fully biological...
Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System
Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 /PRNewswire/ -- Trisol Medical, a...
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Jan. 21, 2025 /PRNewswire/ -- TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving film (ODF). This trial was conducted following detailed discussions...